May 10, 2024
Geisinger enrolls first patient in amyloid cardiomyopathy trial
May 07, 2024
Geisinger Health Plan and OncoHealth to provide comprehensive cancer support to members
Mar 04, 2024
Geisinger names Terry Gilliland, MD, as president and future chief executive officer
Jan 04, 2021
Keeping Nurses Safe on the Frontline: Jefferson and Geisinger Commit to Joint System-wide Deployment of Workplace Violence Prevention Technology
Aug 21, 2020
The National Kidney Foundation Announces First Clinical Partner on NKF Patient Network
Jul 22, 2020
Geisinger Medical Center chosen as hip and knee replacement Center of Excellence
Apr 28, 2020
Geisinger study of blood test for cancer shows promising results
Nov 19, 2019
Geisinger and Medial EarlySign Advance to First Stage of CMS AI Health Outcomes Challenge
Oct 29, 2019
Study shows many common genetic factors determine severity of rare genetic diseases
Jul 10, 2019
Geisinger taps EarlySign for new range of AI solutions to identify patients at risk of high-burden diseases
Mar 14, 2019
OBERD announces new Computer Adaptive Testing (CAT) technology for all AAOS-recommended outcomes instruments
Mar 04, 2019
National Institutes of Health awards Geisinger over $3.1 million for research of sudden cardiac death
Feb 07, 2019
New Home Test for Kidney Damage Shows Promising Results
Nov 15, 2018
Geisinger Launches Surgical Redesign Program to Reduce Opioid Use and Improve Patient Experience
Aug 14, 2018
Geisinger and Merck Unveil New Applications Developed to Help Improve Patient Communication and Care Delivery
Jul 17, 2018
Geisinger and AstraZeneca Create New Asthma App Suite
Apr 10, 2018
Using a Home Test Kit and Smartphone to Test for Kidney Disease
Sep 25, 2017
Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death